Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2.
Journal Information
Full Title: Antiviral Res
Abbreviation: Antiviral Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure statement No potential conflict of interest was reported by the authors. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
"We thank Linqi Zhang at the Tsinghua university (Beijing, China) for providing the plasmids that encode the mutant S proteins of SARS-CoV-2 VOCs. This work was supported by grants from the 10.13039/501100001809National Natural Science Foundation of China (822210040, 82230076) and the CAMS Innovation Fund for Medical Sciences (2021-I2M-1037)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025